![Robert M. Brenner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert M. Brenner
Hoofd Techniek/Wetenschap/O&O bij VERA THERAPEUTICS, INC.
Actieve functies van Robert M. Brenner
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VERA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 08-01-2023 | - |
Loopbaan van Robert M. Brenner
Eerdere bekende functies van Robert M. Brenner
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CODIAK BIOSCIENCES | Hoofd Techniek/Wetenschap/O&O | 01-09-2018 | 01-03-2019 |
Orionis Biosciences, Inc.
![]() Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | Hoofd Techniek/Wetenschap/O&O | 01-12-2015 | 01-09-2018 |
AMAG PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2008 | 04-06-2010 |
AMGEN INC. | Corporate Officer/Principal | 01-07-1999 | 01-05-2008 |
AlloCure, Inc.
![]() AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Directeur/Bestuurslid | 28-12-2010 | - |
Algemeen Directeur | 07-07-2010 | - | |
President | 07-07-2010 | - |
Opleiding van Robert M. Brenner
The Johns Hopkins University | Undergraduate Degree |
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 9 |
Operationeel
Chief Tech/Sci/R&D Officer | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AMGEN INC. | Health Technology |
VERA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
AMAG Pharmaceuticals, Inc.
![]() AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
AlloCure, Inc.
![]() AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Health Technology |
Orionis Biosciences, Inc.
![]() Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | Technology Services |
Codiak BioSciences, Inc.
![]() Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Robert M. Brenner
- Ervaring